Its also unusual that the full proteins sequence was never published, she said, describing the omission as unacceptable under todays standards of scientific practice
That is the most substantial human outcome data currently available for a compound that people are sourcing and injecting based on internet research.[4,5] BPC-157 has been used in Phase II trials for ulcerative colitis and multiple sclerosis.[1,2] Comprehensive published results from those trials are not available in the medical literature
Curley DE, Webb AE, Sheffler DJ, Haass-Koffler CL (2021) Corticotropin releasing factor binding protein as a novel target to restore brain homeostasis: lessons learned from alcohol use disorder research
Read Less PostedMonday, July 6, 2026 at 10:03 AM New admissions timeline
Under 18
Known for its extensively researched protective and regenerative properties, GHK-Cu has been shown to accelerate wound healing and skin repair by stimulating the synthesis and breakdown of collagen, glycosaminoglycans, and other extracellular matrix components